PAC-113 an anti-fungal, for the treatment of oral candidiasis infections. It is a 12 amino-acid antimicrobial peptide derived from a naturally occurring histatin protein found in saliva.
PAC-113, a synthetic antimicrobial peptide derived from the naturally occurring histatin family, represents a significant advancement in the field of carbohydrate-based compounds for research and development. Engineered for enhanced stability and bioactivity, PAC-113 exhibits a distinct structure that enables it to interact with microbial membranes effectively, disrupting their integrity and inhibiting the growth of various pathogenic organisms. Its unique amino acid sequence and cationic nature facilitate strong binding to microbial cell walls, making it a valuable tool for scientific investigations targeting microbial resistance mechanisms. Researchers value PAC-113 not only for its direct antimicrobial properties but also for its potential role in modulating host-pathogen interactions, offering insights into innate immune responses and the development of novel therapeutic strategies.
Antimicrobial Research: PAC-113 is widely utilized in antimicrobial research to study its effects against a broad spectrum of bacteria and fungi. Researchers employ this peptide to evaluate its ability to disrupt microbial membranes, leading to cell lysis and inhibition of microbial proliferation. By incorporating PAC-113 into in vitro models, scientists can investigate its mechanism of action, including its interaction with membrane phospholipids and subsequent induction of membrane permeability. These studies are instrumental in understanding how synthetic peptides can overcome traditional antimicrobial resistance and pave the way for the development of next-generation antimicrobial agents.
Oral Microbiology Studies: In the realm of oral microbiology, PAC-113 serves as a critical tool for examining the dynamics of oral biofilms and pathogenic microorganisms such as Candida albicans and Streptococcus mutans. Researchers utilize this peptide to disrupt established biofilms and prevent their formation, thereby elucidating the role of antimicrobial peptides in maintaining oral health. Through these studies, PAC-113 enables a deeper understanding of how innate defense molecules can be harnessed to manage oral infections and reduce the incidence of dental caries and periodontal diseases.
Biofilm Inhibition Assays: The ability of PAC-113 to inhibit biofilm formation is a focal point in biofilm inhibition assays. Scientists deploy this peptide to assess its efficacy in preventing the adhesion and aggregation of microbial cells on various surfaces, including medical devices and laboratory substrates. By interfering with the initial stages of biofilm development, PAC-113 provides valuable data on the prevention of persistent infections associated with biofilm-producing organisms. These insights contribute to the design of novel coatings and materials that resist microbial colonization, enhancing the safety and longevity of biomedical devices.
Innate Immunity Research: PAC-113 is instrumental in studies exploring the mechanisms of innate immunity, particularly the role of cationic peptides in the first line of defense against pathogens. Researchers investigate how this peptide interacts with host cells and modulates immune responses, shedding light on its potential to enhance or regulate immune function. These findings are crucial for understanding the broader implications of antimicrobial peptides in host defense and for identifying new targets for immunomodulatory therapies.
Peptide Engineering and Structure-Activity Relationship Studies: In the field of peptide engineering, PAC-113 is frequently used as a model compound to investigate structure-activity relationships. Scientists modify specific amino acid residues within its sequence to enhance stability, potency, or selectivity, thereby generating analogs with improved properties. These studies help delineate the structural features responsible for antimicrobial activity and inform the rational design of new peptides with tailored functionalities. By leveraging the insights gained from PAC-113, researchers can accelerate the development of innovative peptide-based compounds for diverse scientific applications.
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More